News 4: Bamlanivimab not easy to pronounce, but provides Texas hospitals new COVID treatment

Dr. Jan Patterson, Infectious Diseases, contributed to a story by News 4 regarding the first shipments of an experimental antibody IV therapy for COVID-19, bamlanivimab, that received emergency authorization from the FDA and which has shown to prevent high-risk patients from ending up in the hospital.

Read and watch the story.

Share This Article!